公司资料
bluebird bio, Inc. 股价、新闻与催化剂
- 股票代码:
- BLUE
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for BLUE.
公司概览
业务概览
bluebird bio was a gene-therapy company focused on severe genetic disease and oncology before its restructuring and exit from the public market. Its legacy was built around one of the earliest commercial gene-therapy platforms.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before restructuring, bluebird sat in gene therapy.
商业模式特征
The business depended on clinical progress, manufacturing, and commercialization of gene-based medicines.
生物医药行业定位
bluebird bio was a landmark gene-therapy company and is now best treated as a legacy platform case.
未来催化剂
- bluebird bio is now mostly a closeout and legacy-asset story, so the next catalysts are any remaining commercial, regulatory, or transaction milestones tied to its gene-therapy portfolio. Investors will watch for clarity on what value, if any, remains after the strategic unwind.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。